Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study-Reference-Cited by-同舟云学术

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Published:2015-05-10 Issue:6 Volume:13 Page:1028-1035
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Francis C. W.¹,Kessler C. M.²,Goldhaber S. Z.³,Kovacs M. J.⁴,Monreal M.⁵,Huisman M. V.⁶,Bergqvist D.⁷,Turpie A. G.⁸,Ortel T. L.⁹,Spyropoulos A. C.¹,Pabinger I.¹⁰,Kakkar A. K.¹¹

Affiliation:

1. University of Rochester Medical Center; Rochester NY USA

2. Georgetown University Hospital; Washington DC USA

3. Brigham and Women's Hospital; Boston MA USA

4. London Health Sciences Centre; London Ontario Canada

5. Hospital Universitari Germans Trias i Pujol; Carretera de Canyet Barcelona Spain

6. Leiden University Medical Center; Leiden the Netherlands

7. University Hospital; Uppsala Sweden

8. Hamilton Health Sciences; McMaster University; Hamilton ON Canada

9. Duke University Medical Center; Durham NC USA

10. Medical University of Vienna; Wien Austria

11. Barts and The London Queen Mary's School of Medicine and Dentistry; London UK

Funder

Eisai

Bayer Healthcare

Boehringer Ingelheim

Bristol-Myers Squibb

Daiichi Sankyo

Pfizer

Sanofi S.A

LEO Pharma

Instrumental Laboratory

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12923/fullpdf

Reference15 articles.

1. Venous thromboembolism and cancer: risks and outcomes;Lee;Circulation,2003

2. Treatment of cancer-associated thrombosis;Lee;Blood,2013

3. Epidemiology of cancer-associated venous thrombosis;Timp;Blood,2013

4. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002

5. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry;Gussoni;Thromb Res,2013

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update;Respiratory Medicine and Research;2023-11

2. Risk of recurrent cancer-associated venous thromboembolism: A Danish nationwide cohort study;International Journal of Cardiology;2023-11

3. Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients;Journal of Clinical Medicine;2023-10-09

4. Traitement de la maladie veineuse thromboembolique au cours du cancer Mise à jour Avril 2023;Revue des Maladies Respiratoires Actualités;2023-10

5. The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis;Cancers;2023-09-20